Investors sold shares of Aetna Inc. (NYSE:AET) on strength during trading on Monday. $75.78 million flowed into the stock on the tick-up and $168.16 million flowed out of the stock on the tick-down, for a money net flow of $92.38 million out of the stock. Of all companies tracked, Aetna had the 5th highest net out-flow for the day. Aetna traded up $3.52 for the day and closed at $155.67

AET has been the subject of several recent research reports. Royal Bank Of Canada restated a “buy” rating and issued a $145.00 price objective on shares of Aetna in a report on Monday, April 24th. Argus restated a “buy” rating and issued a $165.00 price objective (up from $145.00) on shares of Aetna in a report on Tuesday, May 30th. Cowen and Company set a $170.00 price objective on Aetna and gave the company a “buy” rating in a report on Saturday, May 27th. Credit Suisse Group restated a “buy” rating and issued a $155.00 price objective on shares of Aetna in a report on Wednesday, May 17th. Finally, UBS AG restated a “buy” rating and issued a $160.00 price objective (up from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Eight research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $157.09.

The firm has a 50 day moving average price of $154.36 and a 200 day moving average price of $139.60. The firm has a market cap of $51.70 billion, a price-to-earnings ratio of 34.55 and a beta of 0.54.

Aetna (NYSE:AET) last issued its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. During the same quarter last year, the company earned $2.21 EPS. The business’s quarterly revenue was down 2.7% on a year-over-year basis. Equities research analysts forecast that Aetna Inc. will post $9.52 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Thursday, July 13th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.28%. The ex-dividend date was Tuesday, July 11th. Aetna’s dividend payout ratio (DPR) is presently 43.67%.

In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Chairman Mark T. Bertolini sold 103,547 shares of Aetna stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the transaction, the chairman now directly owns 659,888 shares in the company, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Columbus Circle Investors raised its position in Aetna by 358.8% in the first quarter. Columbus Circle Investors now owns 51,831 shares of the company’s stock valued at $6,611,000 after buying an additional 40,535 shares during the period. Nisa Investment Advisors LLC raised its position in Aetna by 2.2% in the first quarter. Nisa Investment Advisors LLC now owns 144,376 shares of the company’s stock valued at $18,415,000 after buying an additional 3,060 shares during the period. Boston Advisors LLC raised its position in Aetna by 20.8% in the first quarter. Boston Advisors LLC now owns 2,906 shares of the company’s stock valued at $371,000 after buying an additional 500 shares during the period. Benin Management CORP purchased a new position in Aetna during the first quarter valued at approximately $250,000. Finally, DnB Asset Management AS raised its position in Aetna by 20.8% in the first quarter. DnB Asset Management AS now owns 118,671 shares of the company’s stock valued at $15,136,000 after buying an additional 20,400 shares during the period. 91.69% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Investors Sell Shares of Aetna Inc. (AET) on Strength (AET)” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.watchlistnews.com/investors-sell-shares-of-aetna-inc-aet-on-strength-aet/1488010.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.